Biomarkers in Participants With Hidradenitis Suppurativa Receiving Guselkumab.

NCT04084665 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped COVID-19 Pandemic

Conditions

Hidradenitis Suppurativa

Interventions

DRUG: Guselkumab

Sponsor

Rockefeller University

Collaborators

[object Object]